Stock Taper 
TMDX
$88.43
▼ DOWN 3.62% (-3.32)
KEY STATISTICS
Market Cap$3.07 B
52w High$156.00
52w Low$60.10
Dividend Yield—
Frequency—
P/E44.89
Volume629.88K
Shares Out.34.56M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Waleed H. Hassanein
COMPENSATION 2026
Salary$776,923
Stock Awards$4,364,013
Incentive Plan Pay$1,400,000
All Other Comp.$14,450
Total$10,915,533
ABOUT
SECTOR
Healthcare
WENT PUBLIC
May 2, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
898
PRICE TARGET
Target High$122.00
Target Low$65.00
Target Median$95.00
Target Consensus$96.86
UPCOMING EARNINGS
DateNov 4, 2026
DayWednesday
Rev. Est.$177.03M
NOV
4
WED
PRICE
$88.43 ▼ DOWN 3.62% (−$3.32)About TransMedics Group, Inc.
https://www.transmedics.com ↗TransMedics Group, Inc. develops portable organ perfusion systems like OCS LUNG, HEART, and LIVER to improve transplantation outcomes for end-stage organ failure patients worldwide.
INDUSTRY
Medical - Devices
A PRODUCT TRANSMEDICS GROUP, INC. IS KNOWN FOR
Organ Care System (OCS)
The Organ Care System (OCS™) is a portable device that preserves and optimizes donor organs outside the body, extending viability and increasing the transplantable organ pool for hearts, livers, and lungs.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Product | $87.68M | $100.39M ▲ | $107.97M ▲ | $111.16M ▲ |
 | Service | $56.15M | — | $65.96M ▲ | $78.79M ▲ |
Revenue by Geography
| Map | REGION | Q3-2022 | Q4-2022 | Q1-2023 | Q2-2023 |
|---|---|---|---|---|---|
 | UNITED STATES | $23.29M | $29.05M ▲ | $37.5M ▲ | $2.82M ▼ |
 | Other Countries | $2.4M | $2.32M ▼ | $4.05M ▲ | $403K ▼ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
194
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
72.46%
HOLDERS
582
TOP 12 OF 582 · RANKED BY POSITION SIZE
Blackrock, Inc.
Fmr LLC
Vanguard Group Inc
Blackrock Inc.
State Street Corp
Ubs Asset Management Americas Inc
Invesco Ltd.
Goldman Sachs Group Inc
Macquarie Management Holdings, Inc.
Macquarie Group Ltd
Geode Capital Management, LLC
Ubs Group AG
RATINGS SNAPSHOT
Overall rating: B
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings2
Price To Book2
Overall Score3
INSIDER TRADES
★
DIRECTOR
TOBIN JAMES R
Sale · 18.0K shares
2026-08-17
★
DIRECTOR, OFFICER: PRESIDENT & CEO
Hassanein Waleed H
Purchase · 113.0K shares
2026-07-10
★
OFFICER: SEE REMARKS
Corcoran Nicholas
Purchase · 11.7K shares
2026-07-10
★
OFFICER: SEE REMARKS
Corcoran Nicholas
Purchase · 17.8K shares
2026-07-10
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 3
NEUTRAL 2
OUTPERFORM 2
OVERWEIGHT 1
HOLD 1
EQUAL WEIGHT 1
10 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 GKOS | $179.99 | COMPARE |
 KYMR | $118.22 | COMPARE |
 BRKR | $57.35 | COMPARE |
 IMVT | $41.71 | COMPARE |
 OSCR | $31.33 | COMPARE |
 HNGE | $89.23 | COMPARE |
 INDV | $34.69 | COMPARE |
 OPCH | $24.01 | COMPARE |